Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.45 |
| ▸ | PPARG | P37231 | 3/20 | 0.45 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.45 |
| ▸ | RXRA | P19793 | 2/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.45 |
| ▸ | F7 | P08709 | 3/20 | 0.42 |
| ▸ | F3 | P13726 | 3/20 | 0.42 |
| ▸ | PPARA | Q07869 | 3/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | PPARD | Q03181 | 2/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5586091 | 1.00 | GABRR1 (0.46) | GABRR1CYP1A2ALDH1A1MAPTCYP19A1 | |
| SCHEMBL5774607 | 1.00 | GABRR1 (0.46) | GABRR1CYP1A2ALDH1A1MAPTCYP19A1 | |
| SCHEMBL469265 | 0.94 | ALDH1A1 (0.55) | ALDH1A1MAPTCYP19A1PPARGOXER1 | |
| SCHEMBL14767921 | 0.94 | ALDH1A1 (0.55) | ALDH1A1MAPTCYP19A1PPARGOXER1 | |
| SCHEMBL14767922 | 0.94 | ALDH1A1 (0.55) | ALDH1A1MAPTCYP19A1PPARGOXER1 | |
| SCHEMBL5407249 | 0.91 | GABRR1 (0.54) | GABRR1CYP1A2ACE2BLM | |
| SCHEMBL5407252 | 0.91 | GABRR1 (0.54) | GABRR1CYP1A2ACE2BLM | |
| SCHEMBL892782 | 0.89 | ALDH1A1 (0.57) | ALDH1A1MAPTCYP19A1PPARGOXER1 | |
| SCHEMBL892781 | 0.89 | ALDH1A1 (0.57) | ALDH1A1MAPTCYP19A1PPARGOXER1 | |
| SCHEMBL5934152 | 0.88 | ALDH1A1 (0.48) | GABRR1CYP1A2ALDH1A1MAPTCYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115710189-B | Method for synthesizing quaternary ammonium salt type surfactant by turpentine downstream product alpha-terpinene | 广西民族大学 | 2024-04-05 | — | — | CN | claimed |
| EP-2226063-B1 | High intensity fragrances | TAKASAGO PERFUMERY CO LTD (JP) | 2013-04-10 | — | — | EP | claimed |
| US-6808859-B1 | DISSOLVED ONLY SLIGHTLY IN DEVELOPING SOLUTIONS, SUPERIOR IN ETCH RESISTANCE, THERMAL RESISTANCE AND ADHESIVENESS; COPOLYMER OF A NORBORNENE CARBOXYLIC ESTER, AND/OR VINYLENE CARBONATE OR MALEIC ANHYDRIDE | HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) | 2004-10-26 | — | — | US | claimed |
| US-6132926-A | ArF photoresist copolymers | HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) | 2000-10-17 | — | — | US | claimed |
| WO-2026101924-A1 | KRAS MODULATORS | ALTEROME THERAPEUTICS, INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| CN-118317992-A | Dual UV blocker comprising a shelf-life stable photoactive bulk polymerized polycycloolefin composition as an optical material | 普罗米鲁斯有限责任公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-114174245-B | Synthesis method of non-racemized cyclohexene | 巴斯夫公司 | 2024-05-10 | — | — | CN | disclosed |
| EP-3440051-B1 | NEUROPEPTIDE S RECEPTOR (NPSR) AGONISTS | RES TRIANGLE INST (US) | 2024-03-20 | — | — | EP | disclosed |
| CN-117417355-A | Fused heterocyclic compound, preparation method and application thereof | 上海翊石医药科技有限公司 | 2024-01-19 | — | — | CN | disclosed |
| CN-116848170-A | Photoactive bulk polymerized polycycloolefin compositions as optical materials that are shelf-life stable for extended periods of time | 普罗米鲁斯有限责任公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-116547270-A | 4- (2-fluoro-4-methoxy-5-3- (((1-methylcyclobutyl) methyl) carbamoyl) bicyclo [2.2.1] hept-2-yl) carbamoyl) phenoxy) -1-methylcyclohexane-1-carboxylic acid derivatives and similar compounds as RXFP1 modulators for the treatment of heart failure | 阿斯利康(瑞典)有限公司 | 2023-08-04 | — | — | CN | disclosed |
| CN-108727369-B | Influenza virus replication inhibitors and uses thereof | 广东东阳光药业有限公司 | 2023-06-09 | — | — | CN | disclosed |
| US-5854277-A | Thiophenebutanoic acid derivatives as matrix metalloprotease inhibitors | BAYER CORPORATION (US) | 1998-12-29 | — | — | US | disclosed |
| US-5852037-A | Method for treating anxiety | ELI LILLY AND COMPANY (US) | 1998-12-22 | — | — | US | disclosed |
| US-5821370-A | MUSCARINIC CHOLINERGIC DRUGS | ELI LILLY AND COMPANY (US) | 1998-10-13 | — | — | US | disclosed |
| US-5821371-A | 1,2,5-THIADIAZOLE COMPOUNDS USEFUL IN THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM CAUSED BY MALFUNCTIONING OF THE MUSCARINIC CHOLINERGIC SYSTEM; COGNITION ACTIVATORS; ALZHEIMER'S DISEASE | ELI LILLY AND COMANY (US) | 1998-10-13 | — | — | US | disclosed |
| US-5801274-A | N- mercaptoacyl(amino acid or peptide)! compounds and S-lipophilic aliphatic carbonyl derivatives thereof as antihypertensives | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 1998-09-01 | — | — | US | disclosed |
| US-5672709-A | INTERMEDIATES FOR DRUGS USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS | ELI LILLY AND COMPANY (US) | 1997-09-30 | — | — | US | disclosed |
| WO-1997017962-A1 | METHOD FOR TREATING ANXIETY | ELI LILLY AND COMPANY (US) | 1997-05-22 | — | — | WO | disclosed |
| US-4413133-A | Process for manufacturing chlorolactones from unsaturated carboxylic acids | INSTITUT FRANCAIS DU PETROLE (FR) | 1983-11-01 | — | — | US | disclosed |